Domain 02 · Dementia Seizure Spectrum
Motor signs that are easy to attribute to the dementia itself, and so are often folded into the diagnosis rather than evaluated.
These are involuntary, repetitive, non-purposeful movements, automatisms originating in the temporal lobe networks most affected early in Alzheimer's disease. Because they closely resemble nervous habits, restlessness, or self-soothing behaviors typical of advancing dementia, they are routinely dismissed. The clinical differentiator is their paroxysmal character: they begin and end abruptly, they are stereotyped (identical in appearance each time), and they typically conclude within 60 seconds.
Automatisms are among the most underrepresented signals in care documentation. The chart language used to record them ("fidgeting," "restless," "agitated") does not trigger neurological evaluation. What gets lost is the defining characteristic: these movements are paroxysmal, stereotyped, and brief. That pattern is what separates a seizure presentation from background dementia behavior.
Three findings from the published evidence base are most relevant to how Domain 2 presentations should be interpreted and documented.
Non-convulsive, focal impaired awareness seizures account for more than 50% of seizure activity in the dementia population. These are not the rare, dramatic presentations, they are the majority. They frequently manifest as the automatisms described in this domain: rhythmic mouth movements and repetitive hand behaviors that are easily mistaken for dementia-related restlessness.
Vossel et al. (2017), The Lancet Neurology · Horváth et al. (2018), Journal of Alzheimer's Disease
Focal temporal lobe seizures in Alzheimer's disease are characterized in the literature by highly stereotyped motor automatisms, rhythmic lip-smacking, chewing, and unpurposeful picking at clothing. The stereotyped, paroxysmal nature of these movements distinguishes them from the continuous restlessness common in dementia. Each occurrence presents identically; episodes have a discrete onset and offset.
Vossel et al. (2013), JAMA Neurology · Lam et al. (2017), Nature Medicine
Movement Change automatisms originate in the temporal and hippocampal networks, precisely the networks most affected in early Alzheimer's disease. Amyloid-beta accumulation disrupts inhibitory interneurons in these circuits, creating a state of chronic disinhibition that allows rhythmic electrical firing to manifest as the repetitive physical movements observed in this domain.
Palop & Mucke (2010), Nature Neuroscience · Busche et al. (2019), Nature Neuroscience
Vague documentation ("agitated," "fidgeting," "restless") obscures the clinical pattern. The features that make a Movement Changes presentation identifiable and escalatable are specific: what the movement was, how long it lasted, whether awareness was affected, and whether it looked the same as previous episodes.
The implementation layer for Domain 2: what a SeizureSafe-trained team does when a Movement Changes presentation is in view.
Rhythmic mouth movements, repetitive picking or fumbling, or rhythmic blinking, especially when onset is abrupt, the movement looks the same each time, and the person appears unaware of or unable to stop it.
Do not attempt to stop or redirect the movement during the episode. Note the start time. Ensure the person is in a safe position. Observe without intervening, the episode will typically resolve within 60 seconds. Stay calm and remain present.
Exact movement, duration, abruptness of onset and offset, whether awareness was affected during the episode, and whether the presentation was consistent with previous occurrences. Replace "fidgeting" or "agitated" with a precise behavioral description.
Report recurring stereotyped automatisms to a neurologist, particularly when accompanied by reduced awareness. Request evaluation for focal impaired awareness seizures. Documented frequency and consistency across episodes is the evidence a neurologist needs to act.
When you need this domain assessed against the literature for a real case, facility, or trial, that's what a CRISP assessment delivers.